SODIUM ROSE BENGAL I 131
Pre-Launchrose bengal sodium i-131
NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium Rose Bengal I-131 is a radioiodinated diagnostic imaging agent delivered via injection. This radiopharmaceutical is used for hepatic imaging and assessment of liver function. The iodine-131 isotope enables visualization of liver tissue uptake and clearance patterns.
Pre-Launch
Pre-launch stage offers entry-level opportunities in regulatory affairs, clinical operations, and launch planning teams; team size and budget allocation remain undetermined.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Rose Bengal I-131 positions you at the ground level of a pre-launch diagnostic product, offering rare exposure to regulatory approval processes and launch strategy development. Early-stage involvement can build expertise in radiopharmaceutical commercialization and establish you as a specialist in emerging nuclear medicine markets.
Regulatory Affairs Specialist
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.